

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lipoprotein transport (GO:0042953) | 8.65199475 |
| 2 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 8.33723958 |
| 3 | intestinal epithelial cell development (GO:0060576) | 8.10114275 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.92794796 |
| 5 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 7.31310951 |
| 6 | lung secretory cell differentiation (GO:0061140) | 7.27527529 |
| 7 | * bile acid and bile salt transport (GO:0015721) | 7.23561527 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 7.21519030 |
| 9 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 7.14214083 |
| 10 | NADH metabolic process (GO:0006734) | 7.08258500 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.86615434 |
| 12 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 6.72130344 |
| 13 | maintenance of gastrointestinal epithelium (GO:0030277) | 6.54779587 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.52216385 |
| 15 | intestinal absorption (GO:0050892) | 6.42218761 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 6.40348441 |
| 17 | regulation of bile acid biosynthetic process (GO:0070857) | 6.15902828 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 6.14909514 |
| 19 | angiotensin maturation (GO:0002003) | 6.13473506 |
| 20 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 6.10335578 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 6.10012167 |
| 22 | macromolecular complex remodeling (GO:0034367) | 6.10012167 |
| 23 | plasma lipoprotein particle remodeling (GO:0034369) | 6.10012167 |
| 24 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.86222836 |
| 25 | regulation of norepinephrine secretion (GO:0014061) | 5.81219625 |
| 26 | fructose metabolic process (GO:0006000) | 5.64732356 |
| 27 | sulfation (GO:0051923) | 5.59873154 |
| 28 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.47739597 |
| 29 | endocrine process (GO:0050886) | 5.47739597 |
| 30 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.47739597 |
| 31 | hormone catabolic process (GO:0042447) | 5.43126830 |
| 32 | cellular glucuronidation (GO:0052695) | 5.42762552 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 5.38914030 |
| 34 | glucuronate metabolic process (GO:0019585) | 5.33509185 |
| 35 | uronic acid metabolic process (GO:0006063) | 5.33509185 |
| 36 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 5.16757438 |
| 37 | glandular epithelial cell differentiation (GO:0002067) | 5.13179830 |
| 38 | drug metabolic process (GO:0017144) | 5.08358183 |
| 39 | epithelial structure maintenance (GO:0010669) | 4.95412039 |
| 40 | regulation of cellular extravasation (GO:0002691) | 4.93093338 |
| 41 | regulation of systemic arterial blood pressure (GO:0003073) | 4.88949496 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.88014873 |
| 43 | phosphatidylserine metabolic process (GO:0006658) | 4.84938135 |
| 44 | regulation of cGMP biosynthetic process (GO:0030826) | 4.83412392 |
| 45 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 4.81885519 |
| 46 | plasma lipoprotein particle organization (GO:0071827) | 4.78443121 |
| 47 | urea cycle (GO:0000050) | 4.75743219 |
| 48 | protein-lipid complex subunit organization (GO:0071825) | 4.72406186 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.68449664 |
| 50 | peptide hormone processing (GO:0016486) | 4.63912013 |
| 51 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.55988314 |
| 52 | flavonoid metabolic process (GO:0009812) | 4.54753812 |
| 53 | glycolipid catabolic process (GO:0019377) | 4.51762510 |
| 54 | urea metabolic process (GO:0019627) | 4.51132398 |
| 55 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.50464639 |
| 56 | glycosphingolipid catabolic process (GO:0046479) | 4.45676590 |
| 57 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.42248885 |
| 58 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 4.36639947 |
| 59 | digestive system process (GO:0022600) | 4.30858231 |
| 60 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.30228449 |
| 61 | mucosal immune response (GO:0002385) | 4.26502358 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 4.25056012 |
| 63 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.20471017 |
| 64 | virion attachment to host cell (GO:0019062) | 4.20080192 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 4.20080192 |
| 66 | nitrogen cycle metabolic process (GO:0071941) | 4.16735587 |
| 67 | negative regulation of cell fate commitment (GO:0010454) | 4.11232797 |
| 68 | regulation of vitamin metabolic process (GO:0030656) | 4.10050451 |
| 69 | actin filament depolymerization (GO:0030042) | 4.06482640 |
| 70 | vitamin transmembrane transport (GO:0035461) | 4.06425574 |
| 71 | fat-soluble vitamin metabolic process (GO:0006775) | 4.05867514 |
| 72 | alditol phosphate metabolic process (GO:0052646) | 4.03848254 |
| 73 | organ or tissue specific immune response (GO:0002251) | 4.03727258 |
| 74 | regulation of cGMP metabolic process (GO:0030823) | 4.01713041 |
| 75 | mRNA modification (GO:0016556) | 4.01322423 |
| 76 | peptide catabolic process (GO:0043171) | 4.01298299 |
| 77 | renal system process involved in regulation of blood volume (GO:0001977) | 4.01157640 |
| 78 | alkaloid metabolic process (GO:0009820) | 3.95012868 |
| 79 | O-glycan processing (GO:0016266) | 3.94651324 |
| 80 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.92626762 |
| 81 | regulation of hormone biosynthetic process (GO:0046885) | 3.91555390 |
| 82 | antimicrobial humoral response (GO:0019730) | 3.91547273 |
| 83 | cellular response to nitric oxide (GO:0071732) | 3.89118857 |
| 84 | drug catabolic process (GO:0042737) | 3.86366614 |
| 85 | protein-lipid complex assembly (GO:0065005) | 3.83976205 |
| 86 | positive regulation of cytokine production involved in immune response (GO:0002720) | 3.83733873 |
| 87 | phosphatidic acid biosynthetic process (GO:0006654) | 3.82249236 |
| 88 | phosphatidic acid metabolic process (GO:0046473) | 3.82249236 |
| 89 | galactose metabolic process (GO:0006012) | 3.80575516 |
| 90 | vitamin transport (GO:0051180) | 3.80453304 |
| 91 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.80315452 |
| 92 | phospholipid efflux (GO:0033700) | 3.70094196 |
| 93 | cGMP biosynthetic process (GO:0006182) | 3.70057459 |
| 94 | homocysteine metabolic process (GO:0050667) | 3.69958052 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.68752986 |
| 96 | cytidine metabolic process (GO:0046087) | 3.68304468 |
| 97 | cytidine catabolic process (GO:0006216) | 3.68304468 |
| 98 | cytidine deamination (GO:0009972) | 3.68304468 |
| 99 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.67791970 |
| 100 | defense response to Gram-positive bacterium (GO:0050830) | 3.61716655 |
| 101 | ceramide catabolic process (GO:0046514) | 3.59724965 |
| 102 | glycosylceramide metabolic process (GO:0006677) | 3.59200676 |
| 103 | midgut development (GO:0007494) | 3.58114285 |
| 104 | digestion (GO:0007586) | 3.56024085 |
| 105 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.54469468 |
| 106 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.53622008 |
| 107 | regulation of hormone metabolic process (GO:0032350) | 3.52793918 |
| 108 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.50703235 |
| 109 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.49568869 |
| 110 | regulation of cholesterol esterification (GO:0010872) | 3.47251760 |
| 111 | vitamin biosynthetic process (GO:0009110) | 3.45946561 |
| 112 | regulation of viral entry into host cell (GO:0046596) | 3.44464107 |
| 113 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.43822599 |
| 114 | regulation of actin nucleation (GO:0051125) | 3.41221734 |
| 115 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.39841504 |
| 116 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.38297011 |
| 117 | positive regulation of pseudopodium assembly (GO:0031274) | 3.38283413 |
| 118 | response to nitric oxide (GO:0071731) | 3.38195331 |
| 119 | vitamin D metabolic process (GO:0042359) | 3.37803361 |
| 120 | positive regulation of glucose import (GO:0046326) | 3.36955836 |
| 121 | arginine metabolic process (GO:0006525) | 3.36353953 |
| 122 | sulfate transmembrane transport (GO:1902358) | 3.36151460 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35529295 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35529295 |
| 125 | sphingomyelin metabolic process (GO:0006684) | 3.34690450 |
| 126 | citrulline biosynthetic process (GO:0019240) | 3.34398119 |
| 127 | drug transport (GO:0015893) | 3.33690747 |
| 128 | glucose 6-phosphate metabolic process (GO:0051156) | 3.32992401 |
| 129 | heme transport (GO:0015886) | 3.32704363 |
| 130 | regulation of protein glycosylation (GO:0060049) | 3.31998876 |
| 131 | positive regulation of cGMP metabolic process (GO:0030825) | 3.30791369 |
| 132 | adhesion of symbiont to host (GO:0044406) | 3.27940216 |
| 133 | cellular response to reactive nitrogen species (GO:1902170) | 3.27854271 |
| 134 | drug transmembrane transport (GO:0006855) | 3.26940344 |
| 135 | sphingolipid catabolic process (GO:0030149) | 3.26629224 |
| 136 | glycoside metabolic process (GO:0016137) | 3.24955178 |
| 137 | cobalamin metabolic process (GO:0009235) | 3.23579474 |
| 138 | negative regulation of steroid metabolic process (GO:0045939) | 3.23209242 |
| 139 | killing of cells of other organism (GO:0031640) | 3.22929207 |
| 140 | disruption of cells of other organism (GO:0044364) | 3.22929207 |
| 141 | positive regulation of lipid catabolic process (GO:0050996) | 3.22832867 |
| 142 | lung cell differentiation (GO:0060479) | 3.22132971 |
| 143 | defense response to fungus (GO:0050832) | 3.21952053 |
| 144 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.20659145 |
| 145 | embryonic process involved in female pregnancy (GO:0060136) | 3.19813183 |
| 146 | phenol-containing compound catabolic process (GO:0019336) | 3.19756546 |
| 147 | leukocyte tethering or rolling (GO:0050901) | 3.18911493 |
| 148 | lung epithelial cell differentiation (GO:0060487) | 3.18761495 |
| 149 | modified amino acid transport (GO:0072337) | 3.18229866 |
| 150 | cholesterol homeostasis (GO:0042632) | 3.17896478 |
| 151 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.15059493 |
| 152 | cellular response to fatty acid (GO:0071398) | 3.14959359 |
| 153 | galactose catabolic process (GO:0019388) | 3.14511015 |
| 154 | phosphatidylglycerol metabolic process (GO:0046471) | 3.13947005 |
| 155 | diacylglycerol metabolic process (GO:0046339) | 3.12433434 |
| 156 | regulation of keratinocyte proliferation (GO:0010837) | 3.04627990 |
| 157 | sulfur amino acid catabolic process (GO:0000098) | 3.04458527 |
| 158 | regulation of cytokine production involved in immune response (GO:0002718) | 3.00665304 |
| 159 | response to hepatocyte growth factor (GO:0035728) | 2.99790071 |
| 160 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.99790071 |
| 161 | drinking behavior (GO:0042756) | 2.99505976 |
| 162 | N-acetylglucosamine metabolic process (GO:0006044) | 2.98630112 |
| 163 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.94352561 |
| 164 | negative regulation of sodium ion transport (GO:0010766) | 2.94346864 |
| 165 | cardiac conduction (GO:0061337) | 2.91254379 |
| 166 | positive regulation of acute inflammatory response (GO:0002675) | 2.91043670 |
| 167 | nucleotide transmembrane transport (GO:1901679) | 2.88867686 |
| 168 | positive regulation of cell fate commitment (GO:0010455) | 2.88658186 |
| 169 | phosphatidylcholine metabolic process (GO:0046470) | 2.88026177 |
| 170 | lipoprotein metabolic process (GO:0042157) | 2.82320266 |
| 171 | positive regulation of glucose transport (GO:0010828) | 2.79630356 |
| 172 | response to histamine (GO:0034776) | 2.78515369 |
| 173 | regulation of podosome assembly (GO:0071801) | 2.78487398 |
| 174 | positive regulation of inflammatory response (GO:0050729) | 2.76879517 |
| 175 | regulation of viral release from host cell (GO:1902186) | 2.72875288 |
| 176 | vitamin A metabolic process (GO:0006776) | 2.71703836 |
| 177 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.70701932 |
| 178 | sulfur compound transport (GO:0072348) | 2.68715394 |
| 179 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66238880 |
| 180 | desmosome organization (GO:0002934) | 2.65649920 |
| 181 | actin filament capping (GO:0051693) | 2.64938199 |
| 182 | antibacterial humoral response (GO:0019731) | 2.64536639 |
| 183 | negative regulation of actin filament depolymerization (GO:0030835) | 2.61682615 |
| 184 | low-density lipoprotein particle remodeling (GO:0034374) | 12.3550095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.38360677 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.02402596 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.96115230 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.63405106 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.38925266 |
| 6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.15733669 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08868640 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.93800814 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.64491465 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.56796726 |
| 11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.51211482 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.43990533 |
| 13 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.32196866 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30178169 |
| 15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.23754267 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14541263 |
| 17 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.01117207 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97403338 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92725751 |
| 20 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.92650476 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83108757 |
| 22 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.80946050 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79023230 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.78439108 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76909430 |
| 26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69225190 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68631340 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68478757 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63744893 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61171765 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60629692 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.59461360 |
| 33 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.52742266 |
| 34 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52663911 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.52537651 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46522078 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44578685 |
| 38 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.43591545 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41487381 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.40924824 |
| 41 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39908370 |
| 42 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39626016 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38856376 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37975836 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37419344 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37322769 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31854191 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25660942 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25361018 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25272973 |
| 51 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23188259 |
| 52 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.22811173 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22578441 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21167455 |
| 55 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.20037721 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.18951531 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18302405 |
| 58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.17407242 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17309948 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15255007 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15172769 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13626118 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13453269 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13402237 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12873279 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12360630 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11744339 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10512757 |
| 69 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09320532 |
| 70 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08995645 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08497632 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08258429 |
| 73 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08073642 |
| 74 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.07906380 |
| 75 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07708679 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06398691 |
| 77 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03601591 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03513809 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03030407 |
| 80 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02811053 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01129605 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.99842184 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98264837 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98246544 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97973821 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97495401 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96882224 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96866423 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96213073 |
| 90 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95974374 |
| 91 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95781391 |
| 92 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.95745499 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95465612 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95329846 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94466688 |
| 96 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93968196 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93943136 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92200492 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91757681 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91644500 |
| 101 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91138830 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90713721 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90547966 |
| 104 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90194676 |
| 105 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.89619311 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89602947 |
| 107 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.89457791 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89113204 |
| 109 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.89097895 |
| 110 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88527942 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88221035 |
| 112 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88069438 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87983568 |
| 114 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86935169 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86766367 |
| 116 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85987463 |
| 117 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84630560 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84095235 |
| 119 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83828902 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83201332 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82612795 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.82225347 |
| 123 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.82220506 |
| 124 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81662085 |
| 125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81207250 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81063062 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80331070 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80162570 |
| 129 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80114956 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79877317 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79851640 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79620726 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79179902 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79084468 |
| 135 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78769382 |
| 136 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78289250 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77329507 |
| 138 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.77105762 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76807468 |
| 140 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74997038 |
| 141 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.74530333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.53986185 |
| 2 | MP0003868_abnormal_feces_composition | 5.43434129 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.49591972 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.99184064 |
| 5 | MP0003183_abnormal_peptide_metabolism | 3.64126062 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 3.43133754 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.23579767 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.03443590 |
| 9 | MP0005365_abnormal_bile_salt | 2.93340248 |
| 10 | MP0001873_stomach_inflammation | 2.93275143 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.87750112 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.87514499 |
| 13 | MP0003866_abnormal_defecation | 2.82810018 |
| 14 | MP0003252_abnormal_bile_duct | 2.55980333 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49103718 |
| 16 | MP0005377_hearing/vestibular/ear_phenot | 2.38904580 |
| 17 | MP0003878_abnormal_ear_physiology | 2.38904580 |
| 18 | MP0004858_abnormal_nervous_system | 2.38477441 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.19970711 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.13885880 |
| 21 | MP0000477_abnormal_intestine_morphology | 2.13683109 |
| 22 | MP0001663_abnormal_digestive_system | 2.11999834 |
| 23 | MP0002822_catalepsy | 2.11449403 |
| 24 | MP0002277_abnormal_respiratory_mucosa | 2.07967566 |
| 25 | MP0000490_abnormal_crypts_of | 2.07151320 |
| 26 | MP0000462_abnormal_digestive_system | 2.03319927 |
| 27 | MP0001664_abnormal_digestion | 2.02039425 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 2.01751721 |
| 29 | MP0005409_darkened_coat_color | 1.93914494 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 1.86134582 |
| 31 | MP0005381_digestive/alimentary_phenotyp | 1.83630654 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.76070819 |
| 33 | MP0005375_adipose_tissue_phenotype | 1.73299782 |
| 34 | MP0005451_abnormal_body_composition | 1.65649238 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.59851459 |
| 36 | MP0001764_abnormal_homeostasis | 1.59512739 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.51439362 |
| 38 | MP0005448_abnormal_energy_balance | 1.51005322 |
| 39 | MP0003718_maternal_effect | 1.49135243 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.47160684 |
| 41 | MP0005165_increased_susceptibility_to | 1.46795912 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.43362374 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.42043218 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.34167924 |
| 45 | MP0009840_abnormal_foam_cell | 1.30260421 |
| 46 | MP0003879_abnormal_hair_cell | 1.30209500 |
| 47 | MP0001188_hyperpigmentation | 1.28702357 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.22189092 |
| 49 | MP0002136_abnormal_kidney_physiology | 1.21702230 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.20523113 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.18255850 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.17875000 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.12398394 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.11271918 |
| 55 | MP0005334_abnormal_fat_pad | 1.08894193 |
| 56 | MP0001849_ear_inflammation | 1.07381407 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.03266941 |
| 58 | MP0005535_abnormal_body_temperature | 1.03167907 |
| 59 | MP0002796_impaired_skin_barrier | 0.97033690 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94983119 |
| 61 | MP0010678_abnormal_skin_adnexa | 0.91046594 |
| 62 | MP0009643_abnormal_urine_homeostasis | 0.90806815 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.88780860 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.86564852 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.85979897 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.84587567 |
| 67 | MP0004270_analgesia | 0.83253643 |
| 68 | MP0005166_decreased_susceptibility_to | 0.82694514 |
| 69 | MP0004043_abnormal_pH_regulation | 0.82441908 |
| 70 | MP0002971_abnormal_brown_adipose | 0.81424601 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.78475613 |
| 72 | MP0005670_abnormal_white_adipose | 0.76827438 |
| 73 | MP0004885_abnormal_endolymph | 0.75138505 |
| 74 | MP0005023_abnormal_wound_healing | 0.74685605 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.74477018 |
| 76 | MP0001756_abnormal_urination | 0.73567687 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.72773158 |
| 78 | MP0004947_skin_inflammation | 0.72227262 |
| 79 | MP0000609_abnormal_liver_physiology | 0.72184639 |
| 80 | MP0010030_abnormal_orbit_morphology | 0.71824279 |
| 81 | MP0008469_abnormal_protein_level | 0.71582053 |
| 82 | MP0005332_abnormal_amino_acid | 0.70937762 |
| 83 | MP0001845_abnormal_inflammatory_respons | 0.69949280 |
| 84 | MP0003724_increased_susceptibility_to | 0.68624119 |
| 85 | MP0006054_spinal_hemorrhage | 0.68416949 |
| 86 | MP0000470_abnormal_stomach_morphology | 0.67581507 |
| 87 | MP0001958_emphysema | 0.65844140 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.64938955 |
| 89 | MP0009785_altered_susceptibility_to | 0.64640283 |
| 90 | MP0002148_abnormal_hypersensitivity_rea | 0.63560437 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.62948122 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.62792098 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.62765704 |
| 94 | MP0008872_abnormal_physiological_respon | 0.61803589 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.60187052 |
| 96 | MP0006138_congestive_heart_failure | 0.58626556 |
| 97 | MP0004859_abnormal_synaptic_plasticity | 0.58107211 |
| 98 | MP0003075_altered_response_to | 0.57884972 |
| 99 | MP0001881_abnormal_mammary_gland | 0.56883709 |
| 100 | MP0010307_abnormal_tumor_latency | 0.56429706 |
| 101 | MP0000249_abnormal_blood_vessel | 0.56411197 |
| 102 | MP0009697_abnormal_copulation | 0.56283966 |
| 103 | MP0009115_abnormal_fat_cell | 0.56255036 |
| 104 | MP0003091_abnormal_cell_migration | 0.55928865 |
| 105 | MP0004147_increased_porphyrin_level | 0.54270555 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.53978613 |
| 107 | MP0009764_decreased_sensitivity_to | 0.53968059 |
| 108 | MP0001440_abnormal_grooming_behavior | 0.53571710 |
| 109 | MP0006082_CNS_inflammation | 0.53233281 |
| 110 | MP0008873_increased_physiological_sensi | 0.52994742 |
| 111 | MP0005501_abnormal_skin_physiology | 0.52165695 |
| 112 | MP0005310_abnormal_salivary_gland | 0.51747718 |
| 113 | MP0003385_abnormal_body_wall | 0.50129754 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.49974887 |
| 115 | MP0003953_abnormal_hormone_level | 0.48872233 |
| 116 | MP0009379_abnormal_foot_pigmentation | 0.48183500 |
| 117 | MP0003303_peritoneal_inflammation | 0.47808436 |
| 118 | MP0000604_amyloidosis | 0.47349357 |
| 119 | MP0005671_abnormal_response_to | 0.47306457 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.46873964 |
| 121 | MP0005025_abnormal_response_to | 0.46473393 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.46426380 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.46098770 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.44335135 |
| 125 | MP0003436_decreased_susceptibility_to | 0.43751073 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.43693844 |
| 127 | MP0001835_abnormal_antigen_presentation | 0.43001871 |
| 128 | MP0005164_abnormal_response_to | 0.42660985 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.42488564 |
| 130 | MP0005387_immune_system_phenotype | 0.42180323 |
| 131 | MP0001790_abnormal_immune_system | 0.42180323 |
| 132 | MP0001533_abnormal_skeleton_physiology | 0.42108242 |
| 133 | MP0005395_other_phenotype | 0.41957681 |
| 134 | MP0008260_abnormal_autophagy | 0.41942774 |
| 135 | MP0000467_abnormal_esophagus_morphology | 0.41804713 |
| 136 | MP0000383_abnormal_hair_follicle | 0.41619545 |
| 137 | MP0009333_abnormal_splenocyte_physiolog | 0.41547595 |
| 138 | MP0002896_abnormal_bone_mineralization | 0.41118858 |
| 139 | MP0009053_abnormal_anal_canal | 0.41000983 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.35591696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.29530792 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 6.19282937 |
| 3 | Micronodular cirrhosis (HP:0001413) | 5.94701074 |
| 4 | Ileus (HP:0002595) | 5.06741485 |
| 5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.74980491 |
| 6 | Hydroxyprolinuria (HP:0003080) | 4.70083453 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 4.70083453 |
| 8 | Bundle branch block (HP:0011710) | 4.48726625 |
| 9 | Abnormality of vitamin B metabolism (HP:0004340) | 4.47568443 |
| 10 | Pigmentary retinal degeneration (HP:0001146) | 4.34386410 |
| 11 | Abdominal distention (HP:0003270) | 4.34359073 |
| 12 | Esophageal varix (HP:0002040) | 4.12876485 |
| 13 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04267255 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 3.98385921 |
| 15 | Chronic diarrhea (HP:0002028) | 3.87821565 |
| 16 | Syncope (HP:0001279) | 3.83588282 |
| 17 | Fat malabsorption (HP:0002630) | 3.77923810 |
| 18 | Nausea (HP:0002018) | 3.74323927 |
| 19 | Malnutrition (HP:0004395) | 3.60815527 |
| 20 | Hyperparathyroidism (HP:0000843) | 3.57990044 |
| 21 | Confusion (HP:0001289) | 3.45778049 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.45310862 |
| 23 | Wide cranial sutures (HP:0010537) | 3.44092212 |
| 24 | Proximal tubulopathy (HP:0000114) | 3.43935027 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.43161344 |
| 26 | Woolly hair (HP:0002224) | 3.40919719 |
| 27 | Intrahepatic cholestasis (HP:0001406) | 3.39732616 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.29564546 |
| 29 | Decreased circulating renin level (HP:0003351) | 3.25399679 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.17159807 |
| 31 | Alkalosis (HP:0001948) | 3.04166846 |
| 32 | Posterior subcapsular cataract (HP:0007787) | 3.01484527 |
| 33 | Prolonged QT interval (HP:0001657) | 2.98330517 |
| 34 | Increased purine levels (HP:0004368) | 2.94189897 |
| 35 | Hyperuricemia (HP:0002149) | 2.94189897 |
| 36 | Hypophosphatemia (HP:0002148) | 2.90975240 |
| 37 | Xanthomatosis (HP:0000991) | 2.86463306 |
| 38 | Oligomenorrhea (HP:0000876) | 2.85407005 |
| 39 | Abnormal urine phosphate concentration (HP:0012599) | 2.84666804 |
| 40 | Enlarged epiphyses (HP:0010580) | 2.84567315 |
| 41 | Metabolic alkalosis (HP:0200114) | 2.76702971 |
| 42 | Hyperammonemia (HP:0001987) | 2.76614318 |
| 43 | Potter facies (HP:0002009) | 2.75127691 |
| 44 | Facial shape deformation (HP:0011334) | 2.75127691 |
| 45 | Hyperglycinuria (HP:0003108) | 2.75099912 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.73109535 |
| 47 | Abnormal foot bone ossification (HP:0010675) | 2.70778600 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.64747391 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 2.63692721 |
| 50 | Steatorrhea (HP:0002570) | 2.63424539 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.62310187 |
| 52 | Palpitations (HP:0001962) | 2.58583487 |
| 53 | Poikilocytosis (HP:0004447) | 2.54421009 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.54242094 |
| 55 | Exocrine pancreatic insufficiency (HP:0001738) | 2.53948880 |
| 56 | Amyloidosis (HP:0011034) | 2.51790766 |
| 57 | Goiter (HP:0000853) | 2.49790114 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.48429205 |
| 59 | Abnormality of the costochondral junction (HP:0000919) | 2.46980615 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.46874855 |
| 61 | Ventricular tachycardia (HP:0004756) | 2.45167641 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.45128457 |
| 63 | Hypoplastic ischia (HP:0003175) | 2.42065990 |
| 64 | Metabolic acidosis (HP:0001942) | 2.41556963 |
| 65 | Hypercortisolism (HP:0001578) | 2.38906304 |
| 66 | Glycosuria (HP:0003076) | 2.37774038 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.37774038 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.37440968 |
| 69 | Abnormal glucose tolerance (HP:0001952) | 2.35112657 |
| 70 | Hypobetalipoproteinemia (HP:0003563) | 2.34336277 |
| 71 | Focal segmental glomerulosclerosis (HP:0000097) | 2.33396049 |
| 72 | Epidermoid cyst (HP:0200040) | 2.33272373 |
| 73 | Hypotension (HP:0002615) | 2.32623938 |
| 74 | Heart block (HP:0012722) | 2.32351748 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.30690149 |
| 76 | Abnormal atrioventricular conduction (HP:0005150) | 2.30631810 |
| 77 | Abnormality of the gastric mucosa (HP:0004295) | 2.30290402 |
| 78 | Hyperlipoproteinemia (HP:0010980) | 2.30052311 |
| 79 | Myopathic facies (HP:0002058) | 2.29425964 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.28176341 |
| 81 | Multiple lipomas (HP:0001012) | 2.18997592 |
| 82 | Subcapsular cataract (HP:0000523) | 2.15729923 |
| 83 | Cerebral palsy (HP:0100021) | 2.12670106 |
| 84 | Protuberant abdomen (HP:0001538) | 2.09458398 |
| 85 | Abnormality of the ischium (HP:0003174) | 2.06892393 |
| 86 | Nephrolithiasis (HP:0000787) | 2.06095566 |
| 87 | Acanthocytosis (HP:0001927) | 2.04588109 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02741280 |
| 89 | Late onset (HP:0003584) | 2.01975606 |
| 90 | Renal tubular acidosis (HP:0001947) | 2.01575992 |
| 91 | Abnormal vertebral ossification (HP:0100569) | 2.01380777 |
| 92 | Renal tubular dysfunction (HP:0000124) | 1.99947367 |
| 93 | Dysmetric saccades (HP:0000641) | 1.99821406 |
| 94 | Irritability (HP:0000737) | 1.99535923 |
| 95 | Atrophic scars (HP:0001075) | 1.98662472 |
| 96 | Gout (HP:0001997) | 1.98298762 |
| 97 | Gastrointestinal dysmotility (HP:0002579) | 1.97373053 |
| 98 | Gingivitis (HP:0000230) | 1.95712743 |
| 99 | Hyperphosphatemia (HP:0002905) | 1.95579006 |
| 100 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94530779 |
| 101 | Progressive hearing impairment (HP:0001730) | 1.92193531 |
| 102 | Congenital, generalized hypertrichosis (HP:0004540) | 1.91613773 |
| 103 | Dehydration (HP:0001944) | 1.89098971 |
| 104 | Hemorrhage of the eye (HP:0011885) | 1.86609530 |
| 105 | Dicarboxylic aciduria (HP:0003215) | 1.85042808 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85042808 |
| 107 | Villous atrophy (HP:0011473) | 1.83044291 |
| 108 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83044291 |
| 109 | Growth hormone excess (HP:0000845) | 1.82771841 |
| 110 | Widely patent fontanelles and sutures (HP:0004492) | 1.82188721 |
| 111 | Pancreatitis (HP:0001733) | 1.81506773 |
| 112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.79415527 |
| 113 | Abnormality of glycine metabolism (HP:0010895) | 1.79415527 |
| 114 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77955402 |
| 115 | Bradycardia (HP:0001662) | 1.77421750 |
| 116 | Metaphyseal irregularity (HP:0003025) | 1.75973980 |
| 117 | Action tremor (HP:0002345) | 1.74724082 |
| 118 | Stridor (HP:0010307) | 1.73775100 |
| 119 | Hemiplegia (HP:0002301) | 1.73716490 |
| 120 | Abnormality of abdominal situs (HP:0011620) | 1.73411545 |
| 121 | Abdominal situs inversus (HP:0003363) | 1.73411545 |
| 122 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73295174 |
| 123 | Thin bony cortex (HP:0002753) | 1.72645259 |
| 124 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72524069 |
| 125 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.71961340 |
| 126 | Glomerulosclerosis (HP:0000096) | 1.71495983 |
| 127 | Abnormal pancreas size (HP:0012094) | 1.70374126 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.69393315 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 1.68351531 |
| 130 | Flat acetabular roof (HP:0003180) | 1.68172135 |
| 131 | Hypoglycemic coma (HP:0001325) | 1.67694864 |
| 132 | Biliary tract neoplasm (HP:0100574) | 1.67405001 |
| 133 | Abnormality of nucleobase metabolism (HP:0010932) | 1.66913138 |
| 134 | Ventricular arrhythmia (HP:0004308) | 1.66907335 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.66680160 |
| 136 | Symptomatic seizures (HP:0011145) | 1.66416249 |
| 137 | Peripheral demyelination (HP:0011096) | 1.66314437 |
| 138 | Abnormal biliary tract morphology (HP:0012440) | 1.65781545 |
| 139 | Patchy hypopigmentation of hair (HP:0011365) | 1.65553684 |
| 140 | Lethargy (HP:0001254) | 1.65345978 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.64597294 |
| 142 | White forelock (HP:0002211) | 1.64435292 |
| 143 | Hoarse voice (HP:0001609) | 1.64080186 |
| 144 | Orchitis (HP:0100796) | 1.63610295 |
| 145 | Childhood onset (HP:0011463) | 1.63454758 |
| 146 | Deep venous thrombosis (HP:0002625) | 1.63237116 |
| 147 | Milia (HP:0001056) | 1.62979367 |
| 148 | Rectal prolapse (HP:0002035) | 1.61573661 |
| 149 | Abnormal hand bone ossification (HP:0010660) | 1.61568400 |
| 150 | Polygenic inheritance (HP:0010982) | 1.61334605 |
| 151 | Agitation (HP:0000713) | 1.61121588 |
| 152 | Pustule (HP:0200039) | 1.60723598 |
| 153 | Abnormal EKG (HP:0003115) | 1.60403644 |
| 154 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.60392766 |
| 155 | Hypoalbuminemia (HP:0003073) | 1.59903731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.50953617 |
| 2 | FRK | 6.73718142 |
| 3 | NME1 | 6.21646317 |
| 4 | RPS6KB2 | 3.98059991 |
| 5 | MST4 | 3.91415610 |
| 6 | PIK3CA | 2.91195498 |
| 7 | STK24 | 2.76640385 |
| 8 | STK39 | 2.74651873 |
| 9 | MAP2K2 | 2.66392238 |
| 10 | ERN1 | 2.54366436 |
| 11 | MST1R | 2.47544998 |
| 12 | TEC | 2.46718432 |
| 13 | PTK6 | 2.32916559 |
| 14 | TAOK1 | 2.21381628 |
| 15 | OXSR1 | 2.19327579 |
| 16 | GRK6 | 2.08893193 |
| 17 | EEF2K | 1.91995508 |
| 18 | EPHB2 | 1.88250977 |
| 19 | BLK | 1.74585424 |
| 20 | MAP3K2 | 1.72601089 |
| 21 | TESK2 | 1.72268654 |
| 22 | LMTK2 | 1.64097823 |
| 23 | TNIK | 1.58689611 |
| 24 | KSR2 | 1.58071093 |
| 25 | EPHA3 | 1.54620191 |
| 26 | CAMK2D | 1.49665981 |
| 27 | TAOK3 | 1.46234049 |
| 28 | LATS1 | 1.41975553 |
| 29 | MAP2K1 | 1.41780279 |
| 30 | AKT3 | 1.39465296 |
| 31 | FGFR4 | 1.39406996 |
| 32 | TYK2 | 1.39337743 |
| 33 | TESK1 | 1.35241606 |
| 34 | MAP3K7 | 1.34683866 |
| 35 | MAP3K11 | 1.32821337 |
| 36 | PRKG2 | 1.27757431 |
| 37 | CAMK2B | 1.24595048 |
| 38 | RIPK1 | 1.15283609 |
| 39 | PIM1 | 1.10929644 |
| 40 | MYLK | 1.10313000 |
| 41 | EPHA4 | 1.08956426 |
| 42 | EPHA2 | 1.05591425 |
| 43 | TRIB3 | 1.04051810 |
| 44 | NLK | 0.96623521 |
| 45 | MAP3K12 | 0.96198285 |
| 46 | MAP3K6 | 0.95358400 |
| 47 | MAP3K10 | 0.95317687 |
| 48 | BMPR2 | 0.93952594 |
| 49 | CAMK2G | 0.92919591 |
| 50 | FGFR3 | 0.89944531 |
| 51 | FER | 0.89461708 |
| 52 | CSK | 0.88175724 |
| 53 | MAP3K1 | 0.85384813 |
| 54 | PAK4 | 0.85127164 |
| 55 | CASK | 0.84027697 |
| 56 | PTK2 | 0.81900354 |
| 57 | PRPF4B | 0.78231966 |
| 58 | STK10 | 0.78076779 |
| 59 | TBK1 | 0.75720676 |
| 60 | LRRK2 | 0.75174869 |
| 61 | MAP3K8 | 0.74992529 |
| 62 | PRKACG | 0.74175798 |
| 63 | ILK | 0.71337636 |
| 64 | NUAK1 | 0.68377070 |
| 65 | RIPK4 | 0.63837444 |
| 66 | ITK | 0.62496254 |
| 67 | MET | 0.61323449 |
| 68 | PRKCZ | 0.60691670 |
| 69 | IRAK1 | 0.58260594 |
| 70 | CAMK1 | 0.56251353 |
| 71 | MAPK11 | 0.55699694 |
| 72 | PAK3 | 0.55363212 |
| 73 | LIMK1 | 0.55088235 |
| 74 | PIK3CG | 0.54482395 |
| 75 | ERBB2 | 0.50435999 |
| 76 | MAP3K3 | 0.47984333 |
| 77 | DDR2 | 0.47545910 |
| 78 | PRKCI | 0.46600386 |
| 79 | YES1 | 0.44898825 |
| 80 | MAPKAPK2 | 0.44416777 |
| 81 | PRKCQ | 0.43493290 |
| 82 | PKN2 | 0.43447028 |
| 83 | TRPM7 | 0.42950618 |
| 84 | JAK1 | 0.41873258 |
| 85 | MAPKAPK3 | 0.41291734 |
| 86 | PRKCE | 0.40715914 |
| 87 | SRC | 0.38916567 |
| 88 | ABL2 | 0.38074697 |
| 89 | NEK6 | 0.37937387 |
| 90 | GRK1 | 0.37483978 |
| 91 | CDK6 | 0.37078331 |
| 92 | RET | 0.36470455 |
| 93 | JAK2 | 0.35744955 |
| 94 | PIM2 | 0.35630711 |
| 95 | PRKAA2 | 0.35088198 |
| 96 | FYN | 0.34430360 |
| 97 | PRKCA | 0.34040240 |
| 98 | CSNK1G3 | 0.33399814 |
| 99 | CSNK1A1 | 0.33184078 |
| 100 | SYK | 0.31093908 |
| 101 | EPHB1 | 0.30147311 |
| 102 | PDPK1 | 0.29497453 |
| 103 | CDK12 | 0.29049620 |
| 104 | BMX | 0.28902067 |
| 105 | CDK19 | 0.27483246 |
| 106 | DYRK1B | 0.27277573 |
| 107 | MAPK15 | 0.27154468 |
| 108 | PAK1 | 0.26772405 |
| 109 | LYN | 0.26465147 |
| 110 | CSF1R | 0.25798840 |
| 111 | CAMK2A | 0.25577056 |
| 112 | IKBKE | 0.25229141 |
| 113 | CSNK1A1L | 0.24971348 |
| 114 | PDK1 | 0.24550520 |
| 115 | ROCK2 | 0.23528180 |
| 116 | PRKACA | 0.23280385 |
| 117 | MATK | 0.23142065 |
| 118 | MAP3K14 | 0.23065138 |
| 119 | MELK | 0.22757956 |
| 120 | CSNK1G2 | 0.22230765 |
| 121 | TAOK2 | 0.22194176 |
| 122 | MAP4K1 | 0.21442109 |
| 123 | MAP2K6 | 0.20718208 |
| 124 | PDK2 | 0.20282100 |
| 125 | ERBB3 | 0.19600249 |
| 126 | ERBB4 | 0.18066420 |
| 127 | DAPK2 | 0.15907329 |
| 128 | CAMKK1 | 0.15362189 |
| 129 | PRKCB | 0.15248103 |
| 130 | DAPK3 | 0.14857943 |
| 131 | PRKCD | 0.13951899 |
| 132 | BTK | 0.13040586 |
| 133 | MAP2K3 | 0.12724284 |
| 134 | CDC42BPA | 0.12633878 |
| 135 | BCR | 0.12379264 |
| 136 | MAPKAPK5 | 0.12093937 |
| 137 | DMPK | 0.11458841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.99837945 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.52854730 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.46863756 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.60884408 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.60295938 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.51434205 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.00941717 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.91310207 |
| 9 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.59713684 |
| 10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.21178792 |
| 11 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.19806332 |
| 12 | Mineral absorption_Homo sapiens_hsa04978 | 2.15156120 |
| 13 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.12302831 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.06293935 |
| 15 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.67917389 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.61021015 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.54327675 |
| 18 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.51366439 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46965594 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36085877 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.31880437 |
| 22 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.31368436 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30802056 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16974976 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15250603 |
| 26 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13543992 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10050377 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04056322 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02190757 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00816866 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98783884 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98487276 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96750826 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94538765 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94309649 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94011152 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93299307 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93138468 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 0.93125950 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81204873 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80673584 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79469912 |
| 43 | Asthma_Homo sapiens_hsa05310 | 0.79244397 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76497220 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76377891 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.74368702 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74273306 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73652857 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72656905 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64642063 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62409615 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60833626 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59428979 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56922390 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56383622 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.55621181 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55249007 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53798538 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52477604 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.52004229 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51789716 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50083813 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.49800933 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49347907 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47937431 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47685049 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47173506 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47125814 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47057841 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45894342 |
| 71 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45002549 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.43294655 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42798184 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.42689863 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42679139 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.40120923 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.39424113 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38427736 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37102448 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36943353 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35238171 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35088497 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34893377 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34455794 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33883895 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33403951 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33106535 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30479196 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29938184 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29906815 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.29873399 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29842229 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29452668 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29138868 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27989384 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.27112683 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.25361743 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25359667 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.24211360 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23951519 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23937626 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23754709 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23653764 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22664101 |
| 105 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.22540983 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22503233 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21267154 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21174907 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20944839 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.20943459 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20571972 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.20403402 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20012667 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.19123126 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17661157 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17611077 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.16940683 |
| 118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16512916 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.15250493 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.15003363 |
| 121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13504435 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11474064 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.10970634 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.09848360 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.09314445 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09126828 |
| 127 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09064525 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08668376 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.08634816 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.08437829 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08300057 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.08072232 |
| 133 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.07316724 |
| 134 | Leishmaniasis_Homo sapiens_hsa05140 | 0.06981707 |
| 135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.04045019 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0521252 |
| 137 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0250731 |
| 138 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0223994 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | -0.0199099 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0066167 |

